![Cancers | Free Full-Text | Prevalence of Sleep Disorders, Risk Factors and Sleep Treatment Needs of Adolescents and Young Adult Childhood Cancer Patients in Follow-Up after Treatment Cancers | Free Full-Text | Prevalence of Sleep Disorders, Risk Factors and Sleep Treatment Needs of Adolescents and Young Adult Childhood Cancer Patients in Follow-Up after Treatment](https://pub.mdpi-res.com/cancers/cancers-14-00926/article_deploy/html/images/cancers-14-00926-g001.png?1644746470)
Cancers | Free Full-Text | Prevalence of Sleep Disorders, Risk Factors and Sleep Treatment Needs of Adolescents and Young Adult Childhood Cancer Patients in Follow-Up after Treatment
![Help! Statistiek! Doorlopende serie laagdrempelige lezingen, voor iedereen vrij toegankelijk. Doel: Informeren over statistiek in klinisch onderzoek. Tijd: Derde. - ppt download Help! Statistiek! Doorlopende serie laagdrempelige lezingen, voor iedereen vrij toegankelijk. Doel: Informeren over statistiek in klinisch onderzoek. Tijd: Derde. - ppt download](https://slideplayer.nl/slide/2178734/8/images/7/kappa+Interpretatie+van+%CE%BA+%28volgens+Altman%29.jpg)
Help! Statistiek! Doorlopende serie laagdrempelige lezingen, voor iedereen vrij toegankelijk. Doel: Informeren over statistiek in klinisch onderzoek. Tijd: Derde. - ppt download
![Frontiers | Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross‐Sectional Descriptive Study as Part of the PharmLines Initiative Frontiers | Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross‐Sectional Descriptive Study as Part of the PharmLines Initiative](https://www.frontiersin.org/files/Articles/512495/fphar-11-00624-HTML/image_m/fphar-11-00624-g003.jpg)
Frontiers | Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross‐Sectional Descriptive Study as Part of the PharmLines Initiative
![Cohen's kappa in SPSS Statistics - Procedure, output and interpretation of the output using a relevant example | Laerd Statistics Cohen's kappa in SPSS Statistics - Procedure, output and interpretation of the output using a relevant example | Laerd Statistics](https://statistics.laerd.com/spss-tutorials/img/ck/crosstabs-cells-cohens-kappa-default-option-checked-v27.png)
Cohen's kappa in SPSS Statistics - Procedure, output and interpretation of the output using a relevant example | Laerd Statistics
![Cohen's kappa in SPSS Statistics - Procedure, output and interpretation of the output using a relevant example | Laerd Statistics Cohen's kappa in SPSS Statistics - Procedure, output and interpretation of the output using a relevant example | Laerd Statistics](https://statistics.laerd.com/spss-tutorials/img/ck/cohens-kappa-crosstabulation-spss-style-v27.png)
Cohen's kappa in SPSS Statistics - Procedure, output and interpretation of the output using a relevant example | Laerd Statistics
![Kappa values and the corresponding 95% Ci are displayed for a selection... | Download Scientific Diagram Kappa values and the corresponding 95% Ci are displayed for a selection... | Download Scientific Diagram](https://www.researchgate.net/publication/327055994/figure/fig1/AS:660231688294401@1534422909626/Kappa-values-for-the-different-time-windows-30-days-90-days-14-90-days-105-days-120_Q320.jpg)
Kappa values and the corresponding 95% Ci are displayed for a selection... | Download Scientific Diagram
![Kappa values and the corresponding 95% Ci are displayed for a selection... | Download Scientific Diagram Kappa values and the corresponding 95% Ci are displayed for a selection... | Download Scientific Diagram](https://www.researchgate.net/publication/327055994/figure/tbl2/AS:670318976839695@1536827906365/Overview-of-all-included-fifth-level-ATC-codes-including-their-respective-kappa-values_Q320.jpg)
Kappa values and the corresponding 95% Ci are displayed for a selection... | Download Scientific Diagram
![Help! Statistiek! Doorlopende serie laagdrempelige lezingen, voor iedereen vrij toegankelijk. Doel: Informeren over statistiek in klinisch onderzoek. Tijd: Derde. - ppt download Help! Statistiek! Doorlopende serie laagdrempelige lezingen, voor iedereen vrij toegankelijk. Doel: Informeren over statistiek in klinisch onderzoek. Tijd: Derde. - ppt download](https://slideplayer.nl/slide/2178734/8/images/8/Enkele+aspecten+van+kappa.jpg)